Gongwin Biopharm Holdings Co., Ltd.

NT$100.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6617Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 2.33%
Div yield —
ROE (7.36%)
Biotechnology
Beta (5Y) 0.45
PE TTM —
TSR TTM 3.08%
Mkt cap NT$12.17B
ROIC (5.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$108
7.27%
178.28%
Hold 6|5|6|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.04
1.13
1.20
1.26
(4.99%)
8.93%
14.12%
15.68%
RevenueNT$B
0.943
0.990
1.001
0.982
5.63%
13.81%
10.49%
10.21%
Peers (US$367.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.748
0.129
0.128
EBIT/Intx
0.152
0.068
0.068
Own earn%
(52.68)
(135.60)
(142.29)
Sh yield%
29.26
37.13
38.91
Owners
Insiders/Inst%
11.81
84.72
Short interest%
4.88
SBC / revenue%
4.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
1–6
$1 testx
—
Incr. ROIC%
2